A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation.

Source:http://linkedlifedata.com/resource/pubmed/id/12393894

J. Biol. Chem. 2002 Dec 27 277 52 50386-95

Download in:

View as

General Info

PMID
12393894